https://www.selleckchem.com/pr....oducts/azd0156-azd-0
0001) and -16.5±4.7mg/dl ( =.0005), respectively. Teneligliptin yielded significant changes in HbA1c (-0.81%; .0001) and FPG (-22.2mg/dl; .0001) at Week 12. At Week 24, more patients achieved HbA1c 7.0% with teneligliptin (41.7%) compared with placebo (16.1%; .0001). Treatment-emergent AE incidence was similar with teneligliptin (58.9%) and placebo (68.3%); upper respiratory tract infection, hyperuricaemia and hyperlipidaemia were the most common AEs. Teneligliptin 20mg qd for 24weeks added to ongoing metformin
Like
Comment
Share
